Shield Therapeutics Plc Stock Price Patterns
| SHIEF Stock | USD 0.15 0.00 0.00% |
Momentum 55
Impartial
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate trading signals. We use our internally-built news screening methodology to estimate the value of Shield Therapeutics based on different types of headlines from major news networks to social media. Using Shield Therapeutics hype-based prediction, you can estimate the value of Shield Therapeutics plc from the perspective of Shield Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Shield Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Shield Therapeutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Shield because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Shield Therapeutics after-hype prediction price | USD 0.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Shield |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Shield Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Shield Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Shield Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Shield Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Shield Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Shield Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Shield Therapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Shield Therapeutics' historical news coverage. Shield Therapeutics' after-hype downside and upside margins for the prediction period are 0.01 and 6.26, respectively. We have considered Shield Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Shield Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Shield Therapeutics plc is based on 3 months time horizon.
Shield Therapeutics OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Shield Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Shield Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Shield Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.96 | 6.11 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.15 | 0.15 | 0.00 |
|
Shield Therapeutics Hype Timeline
Shield Therapeutics plc is at this time traded for 0.15. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Shield is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.96%. %. The volatility of related hype on Shield Therapeutics is about 305500.0%, with the expected price after the next announcement by competition of 0.15. About 42.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Shield Therapeutics plc recorded a loss per share of 0.11. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out Shield Therapeutics Basic Forecasting Models to cross-verify your projections.Shield Therapeutics Related Hype Analysis
Having access to credible news sources related to Shield Therapeutics' direct competition is more important than ever and may enhance your ability to predict Shield Therapeutics' future price movements. Getting to know how Shield Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Shield Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORXOF | Orexo AB | 0.00 | 0 per month | 0.00 | 0.01 | 0.00 | 0.00 | 5.90 | |
| GGBXF | Green Growth Brands | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PFGTF | Pacific Edge Limited | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | 0.00 | 99.18 | |
| LOVFF | Cannara Biotech | 0.00 | 0 per month | 2.24 | 0 | 6.56 | (4.07) | 12.47 | |
| JUSHF | Jushi Holdings | 0.00 | 0 per month | 9.54 | 0.04 | 18.33 | (10.77) | 104.05 | |
| POLBF | Poolbeg Pharma PLC | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | |
| BIOYF | Biosyent | (0.02) | 4 per month | 2.31 | 0.15 | 4.79 | (2.26) | 24.61 | |
| HLTRF | HLS Therapeutics | 0.00 | 0 per month | 0.00 | (0.34) | 0.00 | (1.44) | 4.32 | |
| GRUSF | Grown Rogue International | 0.00 | 0 per month | 4.89 | 0.04 | 8.70 | (7.50) | 48.44 | |
| KNTPF | Kintor Pharmaceutical Limited | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 32.99 |
Shield Therapeutics Additional Predictive Modules
Most predictive techniques to examine Shield price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Shield using various technical indicators. When you analyze Shield charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Shield Therapeutics Predictive Indicators
The successful prediction of Shield Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Shield Therapeutics plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Shield Therapeutics based on analysis of Shield Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Shield Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Shield Therapeutics's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Shield OTC Stock analysis
When running Shield Therapeutics' price analysis, check to measure Shield Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shield Therapeutics is operating at the current time. Most of Shield Therapeutics' value examination focuses on studying past and present price action to predict the probability of Shield Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shield Therapeutics' price. Additionally, you may evaluate how the addition of Shield Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |